FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Real-time BOERSE MUENCHEN 15:46:45 2024-06-24 EDT | ||
| 7.53 EUR | -7.04% |
|
| Current month | -7.61% | ||
| 1 month | -22.21% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-24 | 7.53 | -7.04% |
| 24-06-21 | 8.1 | +5.47% |
| 24-06-20 | 7.68 | -6.23% |
| 24-06-19 | 8.19 | +1.74% |
| 24-06-18 | 8.05 | +6.20% |
Real-time BOERSE MUENCHEN
Last update June 24, 2024 at 03:46 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD36C4 |
| ISIN | DE000HD36C46 |
| Date issued | 2024-02-28 |
| Strike | 271.9 $ |
| Maturity | Unlimited |
| Parity | 6.11 : 1 |
| Emission price | 10.94 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.48 € |
|---|---|
| Lowest since issue | 6.17 € |
| Spread | 0.2 € |
| Spread % | 2.62% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
226.6
USD
Average target price
284.6
USD
Spread / Average Target
+25.61%
- Stock Market
- Certificates
- Certificat
